Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

NCT00699192 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

965

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Amlodipine 5 mg
DRUG: Valsartan 80 mg
DRUG: Valsartan 40 mg
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals